$QNT

Daugherty Paul R. purchased $240K of QNT

Daugherty Paul R. purchased 4,000 shares of Quantinuum Inc. (QNT) at $60.00 ($0.24M total) on 2026-06-05.

Original reporting
SEC EDGAR · Daugherty Paul R.
Published Jun 8, 2026, 8:31 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 8, 2026, 8:32 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$QNT
Bullish
medium confidence
Mentioned
$QNT
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$QNTBullishLow
01

Why it matters

A director’s open-market purchase adds a small sentiment datapoint but does not change earnings, guidance, or risk materially on its own.

02

Market read

Traders may treat this as a minor positive sentiment signal, but it’s unlikely to drive a sustained repricing without additional catalysts.

03

What to watch

Check whether the director has a history of buys/sells and whether other insiders or large holders are changing positions around the same period.

Relevance 5/10Novelty 8/10Timing: Filed 2026-06-08 (transaction dated 2026-06-05)

Background

The article summarizes an SEC Form 4 insider transaction for Quantinuum (QNT).

Company-level read

Ticker impact

$QNTBullishMedium confidence
Context

Director Paul R. Daugherty bought 4,000 shares of Quantinuum on 2026-06-05 for ~$240K, per a fresh SEC Form 4.

Expected impact

Likely limited near-term impact; any effect should be small and sentiment-driven.

Evidence & confidence

The filing is primary-source and time-stamped, but the transaction is a single director buy with no accompanying corporate action, guidance, or contract news.

Market effects

No clear sector read-through; this is a company-specific insider transaction without broader industry signals.

None indicated.

None indicated.

Counterpoint

Insider buys can be discretionary and may not reflect near-term fundamentals; without a 10b5-1 plan, timing could be opportunistic.

Key entities

  • Quantinuum Inc.

    Subject of the SEC Form 4 insider transaction; director Paul R. Daugherty purchased shares.

  • Paul R. Daugherty

    Director who reported an open-market purchase of 4,000 shares on 2026-06-05.

Related articles

$HONMed

Honeywell (NASDAQ: HON) Q2 2026 profit surges on Quantinuum gain

Honeywell (HON) amended its Q2 2026 report to correct segment backlog presentation. It said Q2 and YTD 2026 net sales rose 4% and 3%. Profit was boosted by a $6,629 million gain from Quantinuum deconsolidation, while backlog rose 12% to $38,008 million. The filing also cites margin pressure, $311 million impairments, and a $241 million debt-extinguishment loss.

$QNTMed

Why Is Quantinuum Stock Surging On Thursday? - Quantinuum (NASDAQ:QNT)

Quantinuum (NASDAQ:QNT) shares rose 6.37% to $54.67 Thursday as traders bought after the stock rebounded from its IPO floor. The company, based in Broomfield, Colorado, said it priced an upsized IPO of 28,000,000 Class A shares at $60 each, raising $1.68 billion in gross proceeds, and it cited ongoing commercialization and customer engagements across multiple sectors.